New Website Coming! As part of our merger with St. Paul Research, we’re creating a new website that will house all of our collective content under one roof, bringing you a higher level of research and service through their analysts’ additional insight, expertise, and perspective. Be on the lookout for more information in advance of our new website launch on Tuesday, May 18.

Technology Profits Confidential

The world of tech and biotechnology will provide endless opportunity for growth and wealth for investors who know where to look.

Technology Profits Confidential is your one-stop shop for the companies of tomorrow's technology... and how you can profit from them.

Buy the Yellen Dip: This Hated Small Biotech Company Becomes a Buyout Candidate

Biotech firms are taking a lot of heat lately. Gilead Sciences, for example, is being dragged back before government entities to defend the pricing of a hepatitis C drug that not only saves more lives than anything that's come before it but does so more cheaply than previous alternatives (see your June issue for details). It works so well that people are breaking the door down to get it, which is straining our already strained (and broken) socialized medical programs.

What regulators and lawmakers seem to forget is that without profits to fund expensive clinical drug discovery and development, we'd be dropping like flies from diseases that have long been tossed in history's dustbin. Furthermore, without expectation of future returns, new drugs for diseases that could kill us will simply not appear.

You Must Be A Subscriber To View This Content.

If you are already a subscriber, click the login button below to get access. Not yet a subscriber? Checkout our publication below and get access today!

Technology Profits Confidential

With new technologies in mobile computing, biotechnology and 3-D printing, it’s nearly impossible to keep up with the throngs of new innovation and still be able to forecast which companies are set to profit. Technology Profits Confidential is your one-stop shop for the companies of tomorrow’s technology… and how you can profit from them.


Ray Blanco

Ray Blanco is the editor of Technology Profits Confidential as well as Breakthrough Technology Alert, FDA Profit Alert, and Technology Profits Daily. Ray has been with Seven Figure Publishing since 2010. In 2019, his closed positions in Technology Profits Confidential outperformed the S&P500 by 50%.

View More By Ray Blanco